Biomarkers Correlating With the Development of Oral Squamous Cell Carcinoma From Leukoplakia
Oral Diseases · 10.08.2026
DOI: 10.1111/odi.70439 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, online erschienen am 10.08.2026. Verfasst von Daniel Giglio und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Swedish governmental funding of clinical research (TUA), King Gustav V Jubilee Clinic Cancer Research Foundation, Tokyo University of Agriculture.
Abstract (Originalsprache)
Background
We assessed protein biomarkers expressed in oral leukoplakia (OL) that are associated with the risk of transformation into oral squamous cell carcinoma (OSCC).
Methods
Tissue sections of OL transforming into OSCC (leuko‐ca), the corresponding OSCC and OL that did not progress to OSCC (leuko‐nonca) were analyzed with global relative quantification to compare proteome profiles. Immunohistochemistry was performed to validate the expression of identified biomarkers.
Results
The top enriched biological pathways in OL transforming into OSCC within 5–26 months after diagnosis (short duration [SD]‐leuko‐ca) compared with leuko‐nonca were pathways regulating remodeling of the extracellular matrix (ECM) and lipid and cholesterol metabolism/transport. Kininogen‐1, apolipoprotein E (ApoE), collagen alpha‐1 (XVIII) chain (COL18A1), sortilin, and perlecan were the most downregulated proteins, whereas EEF1D was the most upregulated in SD‐leuko‐ca compared with leuko‐nonca. Immunohistochemistry confirmed the expression of kininogen‐1, ApoE, perlecan, and EEF1D in OL and OSCC. In OSCC compared with leuko‐ca, enriched biological pathways involved keratinocyte and epithelial differentiation and immune response regulation.
Conclusion
We identified biomarkers in OL that were associated with the risk of malignant transformation. Our study gives further support for the importance of the immune system, ECM remodeling, and lipoproteins and cholesterol metabolism in the progression of OL to OSCC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Medicine and Oncology, Southern Älvsborg Hospital, Borås, Sweden.
- Department of Oral Medicine and Pathology, Institute of Odontology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
- Institute of Oral Biology, University of Oslo, Oslo, Norway.
- Proteomics Core Facility, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
- Department of Clinical Pathology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
ORCID-Profile: Daniel Giglio, Tine Merete Søland, Dipak Sapkota, Bengt Hasséus
Förderung
- The Swedish governmental funding of clinical research (TUA)
- King Gustav V Jubilee Clinic Cancer Research Foundation
- Tokyo University of Agriculture
Zitieren
APA
Giglio, D., Ganesh, D., Bhattarai, B. P., Søland, T. M., Sundberg, J., Thorsell, A., Öhman, J., Sapkota, D., & Hasséus, B. (2026). Biomarkers Correlating With the Development of Oral Squamous Cell Carcinoma From Leukoplakia. Oral Diseases. https://doi.org/10.1111/odi.70439
Vancouver
Giglio D, Ganesh D, Bhattarai BP, Søland TM, Sundberg J, Thorsell A, et al. Biomarkers Correlating With the Development of Oral Squamous Cell Carcinoma From Leukoplakia. Oral Diseases. 2026. doi:10.1111/odi.70439
BibTeX
@article{Giglio2026,
author = {Giglio, Daniel and Ganesh, Divya and Bhattarai, Bishwa Prakash and Søland, Tine Merete and Sundberg, Jonas and Thorsell, Annika and Öhman, Jenny and Sapkota, Dipak and Hasséus, Bengt},
title = {Biomarkers Correlating With the Development of Oral Squamous Cell Carcinoma From Leukoplakia},
journal = {Oral Diseases},
year = {2026},
doi = {10.1111/odi.70439}
}
EUVIMED